Skip to content

IQVIA HOLDINGS INC.

IQV · XNYS

CIK 1478242fmd_1NEDCFTATP6J1E6A5VT7KRXCTJServices · Services-Commercial Physical & Biological ResearchTemplate: Standard

Coverage: Jan 01, 2011 to Sep 30, 2026, 60 periods

Income Statement · Annual · Millions · USD
Line itemFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Total revenues6,8159,70210,41211,08811,35913,87414,41014,98415,40516,310
Cost of revenue3,2364,622––––––––
Gross profit3,5795,080––––––––
Realized investment gains (losses)––––––––––
Research and development––––––––––
Selling, general and administrative1,0161,6221,7161,7341,7891,9642,0712,0531,9921,999
Operating income5766657417777311,3931,7991,9772,2022,182
Interest expense144346414447416375416672670729
Interest and investment income47896613364745
Other non-operating income (expense)11(13)(5)3765130(33)1249099
Income before taxes4162943283523731,1281,3631,4591,6691,591
Income tax expense325(992)5911672163260101301252
Net income from continuing operations911,2862692363019651,1031,3581,3681,339
Net income721,2772591912799661,0911,3581,3731,360